The research showed that the knockdown of TRAIL-R2 diminished the HMGA2, p-Akt and CXCR4 expression, thereby suppressing diminish of the skeletal metastasis in BC (Pan et al. 1997; Azijli et al. 2013). This evidence concerns the gene TNFRSF10B and breast cancer.